A study to check the safety & benefit of medicine Trivoglitor in patients with type 2 diabetes mellitus.
Not Applicable
- Conditions
- Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
- Registration Number
- CTRI/2023/06/053828
- Lead Sponsor
- Torrent Pharmaceuticals Ltd,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Uncontrolled T2DM >= 7% HbA1c, FBG > 100 mg/dL & PPBG >= 200 mg/dL
2) Patients of either sex, above 18 years of age with T2DM and who had received treatment with FDC of glimepiride, metformin sustained release (SR) and voglibose of any strength
Exclusion Criteria
1) Patients who had incomplete data or any condition that according to the discretion of the investigator indicated that the patient is not suitable for the study were excluded. Duration
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method